Q32 Bio Total Assets

Q32 Bio (QTTB) currently reports a total assets of $300M as of September 2026. That compares with $58M in the prior-year period — up 414.3% year over year. Use the charts on this page to explore Q32 Bio's total assets history and peer comparisons.

Q32 Bio's total assets increased from $58M to $300M — a 414.3% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Q32 Bio reported $300M in total assets as of September 2026. That compares with $58M in the prior-year period — up 414.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $300M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Q32 Bio, and consider following QTTB for alerts when major investors trade the stock.

Q32 Bio is classified in the Healthcare sector. On total assets, it currently shows $300M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing QTTB with unrelated industries.